Clinical trial
Long-Term Safety of Febuxostat in Subjects With Gout.
NCT00174941 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00174941 |
|---|---|
| Title | Long-Term Safety of Febuxostat in Subjects With Gout. |
| Official title | Phase II, Open-Label Study, to Assess the Long-Term Safety of Oral TMX-67 in Subjects With Gout |
| Acronym | FOCUS |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gout |
| Intervention type | Drug |
| Interventions | Febuxostat |
| Enrollment | 116 |
| Start date | Mar 1, 2001 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 27, 2011 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: